EGR1 is an early growth response zinc finger transcription factor with broad actions, including in differentiation, mitogenesis, tumor suppression, and neuronal plasticity. Here we demonstrate that Egr1 −/− mice on the C57BL/6 background have normal eyelid development, but back-crossing to BALB/c background for four or five generations resulted in defective eyelid development by day E15.5, at which time EGR1 was expressed in eyelids of WT mice. Defective eyelid formation correlated with profound ocular anomalies evident by postnatal days 1-4, including severe cryptophthalmos, microphthalmia or anophthalmia, retinal dysplasia, keratitis, corneal neovascularization, cataracts, and calcification. The BALB/c albino phenotype-associated Tyr c tyrosinase mutation appeared to contribute to the phenotype, because crossing the independent Tyr c-2J allele to Egr1 −/− C57BL/6 mice also produced ocular abnormalities, albeit less severe than those in Egr1 −/− BALB/c mice. Thus EGR1, in a genetic backgrounddependent manner, plays a critical role in mammalian eyelid development and closure, with subsequent impact on ocular integrity.
Egr1 | eyelid development | ocular abnormalities | tyrosinase | genetic background-specific effects T he early growth response (Egr) family genes, Egr1, Egr2, Egr3, and Egr4, are rapidly induced by cell-surface receptor signaling and regulate gene expression in response to a range of mitogenic signals in multiple cell types (1) . Human EGR1, also known as ZIF268, NGFI-A, KROX24, TIS8, and ZENK, was first identified as a regulator of the cell cycle (G0/G1 switch) in peripheral blood lymphocytes (2) . Sequence analysis of mouse Egr1 indicated that it was a DNA-binding protein with three highly conserved Cys 2 -His 2 zinc finger domains (3) , and Egr1 was established as a transcription regulator (4) that binds to a 5′-GCG TGG GCG-3′ motif. EGR1 has been suggested to have multiple actions, including in differentiation (5, 6) , as a tumor suppressor (7, 8, 9) , and as a mediator of neuronal plasticity (10, 11) . Moreover, EGR1 is expressed in T cells and thymocytes, with actions promoting positive selection of both CD4
+ and CD8 + thymocytes (12) and T-cell activation in part by enhancing IL-2 transcription (13) .
While studying the role of EGR family proteins in T-cell biology (14) , we unexpectedly observed ocular abnormalities associated with Egr1 deficiency that depended on the genetic background. No abnormalities were observed in Egr1 −/− C57BL/6 mice, but as these animals were progressively crossed toward the BALB/c background, we observed profound anomalies in adult and newborn mice, including cryptophthalmos, anophthalmia or severe microphthalmia, retinal dysplasia, keratitis, corneal neovascularization, cataracts, and calcification, indicating the importance of the mouse background and the possibility for strain-specific modifier genes affecting eye development. Interestingly, the phenotype was variable, even within the two eyes in a single mouse, indicating variable penetrance. Importantly, during embryonic development, although early development of the eye was normal in Egr1 −/− (BALB/c background) mice, these animals exhibited defective eyelid formation and closure, whereas this defect was not observed in Egr1 −/− C57BL/6 mice. Furthermore, we confirmed EGR1 expression in the developing eyelid by immunohistochemistry. We also show that crossing the Tyr c-2J
-null allele to Egr1 −/− C57BL/6 mice results in ocular abnormalities; however, these abnormalities were less severe than those that occur in the Egr1 −/− BALB/c mice, which naturally contain the Tyr c mutation. Overall, our data indicate that Egr1 deficiency results in abnormal eyelid development and closure in a genetic background-dependent manner, predisposing to a range of ocular abnormalities.
Results

Ocular Anomalies in Egr1
−/− BALB/c but not Egr1
mice on the C57BL/6 background were backcrossed to the BALB/c background. Although no abnormalities were observed in Egr1
and Egr1 −/− C57BL/6 mice (Fig. 1A ) or in Egr1 +/+ and Egr1
BALB/c mice after five generations of backcrossing (Fig. 1B) , substantial abnormalities were observed at the F5 Egr1 −/− BALB/c generation, including cryptophthalmos (narrow palpebral fissure), microphthalmia (small eye size) and, in some mice, opaque cornea (Fig. 1C) . Compared with normal mice (Fig. 1D) , histological
Significance
Eyelid formation begins at approximately day E15.5 in mice. Over the next 24 h, the epidermis of both upper and lower eyelids rapidly grows and merges to cover the cornea. Here, we demonstrate that Egr1 −/− mice on the C57BL/6 background have normal eyelid development, but back-crossing to BALB/c background for four or five generations resulted in defective eyelid development by embryonic day E15.5. This defective eyelid formation was then further associated with profound ocular anomalies evident by postnatal days 1-4. The BALB/c albino phenotype associated with the Tyr c tyrosinase mutation also appeared to contribute to the phenotype. Thus EGR1 in a genetic background-dependent manner plays a critical role in mammalian eyelid development, with subsequent impact on ocular integrity.
analysis revealed anophthalmia (absence of one or both eyes) (Fig.  1E ), severe microphthalmia (Fig. 1F), retinal dysplasia (Fig. 1G) , cataracts ( Fig. 1 H and I) , keratitis ( Fig. 1 H-J) , corneal neovascularization ( Fig. 1 H-J) , and/or calcification ( Fig. 1H and Table  1 ). Interestingly, the severity of defects often varied substantially between the two eyes in the same mouse, indicating variable penetrance of the phenotype even within a single animal.
These results suggested that Egr1 deficiency conferred these ocular abnormalities on the BALB/c but not the C57BL/6 background, but conceivably a de novo mutation in another gene might have occurred spontaneously during backcrossing. We thus performed a second independent backcross of Egr1 −/− C57BL/6 mice to the BALB/c background, and by the F4 generation the Egr1 −/− but not Egr1 +/− or Egr1 +/+ mice again showed ocular anomalies similar to those of the first backcross, including anophthalmia (Fig.  S1A ), severe microphthalmia (Fig. S1B ), retinal folds (Fig. S1C) , keratitis/corneal neovascularization (Fig. S1D) , and cataracts ( Fig. S1D and Table 1 ). These results confirmed that Egr1 mutation was indeed responsible for the eye defects on the BALB/c background, underscoring the importance of the genetic background and the possibility of contributions from strain-specific modifier gene(s).
Abnormal Eyelid Formation in Egr1
−/− BALB/c Embryos and Ocular Abnormalities After Birth. To determine how early the ocular abnormalities occurred, we next studied 1-to 4-d-old mice. As expected, eyes from Egr1 +/+ and Egr1 +/− BALB/c mice were normal (Fig. 2A) ; however, histological analysis showed mild corneal neovascularization and keratitis abnormalities in Egr1 −/− BALB/c mice at postnatal days 1 and 2 ( Fig. 2B and Table S1 ). In one case, an eye was severely malformed (Fig. 2C) . At postnatal days 3 and 4, Egr1 −/− BALB/c mice exhibit a greater severity, including microphthalmia, keratitis, and corneal neovascularization as well as corneal melting and perforation ( Fig. 2 D and E) , vitreous hemorrhage (Fig. 2 E and F) , inflammation (Fig. 2 E) , and retinal detachment (Fig. 2 E and F) or only residual remnant retina (Fig. 2G ) (abnormalities are summarized in Table S1 ). In addition to these abnormalities, a striking finding was that although all Egr1 +/+ and Egr1 +/− BALB/c mice had normal palpebral fissures and thus had normally closed eyelids ( Fig. 2 H and I) , 13 of 16 Egr1 −/− BALB/c mice had no evidence of eyelid formation and closure at postnatal days 1-4 ( Fig. 2J and Table S1 ). Importantly, when eyelids were normally closed in Egr1 −/− BALB/c mice, the ocular structure was either normal or had only mild anomalies, compared with mice with unformed eyelids (Table S1 ), suggesting a causal relationship between the failure of normal eyelid closure and ocular damage.
In mice, eyelid formation is not evident at day E13.5, but the epidermis of both upper and lower eyelids grows rapidly and merges to cover the cornea at approximately day E15.5 over the next 24 h (15-17). To identify when defective eyelid formation occurred,
Egr1
+/− and Egr1 −/− BALB/c embryos were analyzed. At day E16.5, 4 Egr1 +/− BALB/c embryos showed epidermis growth, with four of eight embryos having completely merged eyelids and the other four having one eyelid merged (Fig. 3A, Right) and the other still only partially merged (Fig. 3A , Left, and Table S2 ). In contrast, all seven Egr1 −/− embryos had defective eyelid formation; fusion was completely defective in four of the seven cases and was partial in the other three ( Fig. 3B and Table S2 ). In all E17.5 and E18.5 Egr1 +/− BALB/c embryos, both eyelids were completely merged ( Fig. 3 C and E), in marked contrast to the defective eyelid formation in all Egr1 −/− BALB/c embryos ( Fig. 3 D and F and Table  S2 ). Despite deformed eyelid formation, the internal ocular structure was relatively normal in all Egr1 −/− BALB/c embryos, indicating that the ocular anomalies observed postnatally and in adults, as shown in Fig. 1 , occurred later than day E18.5.
Egr1 Is Expressed in the Eyelid During Embryogenesis. Because of the defective eyelid formation, we next investigated whether the Egr1 gene is expressed in the eyelid during embryogenesis. Serial sections of E13.5, E15.5, and E17.5 embryos from C57BL/6 WT mice were stained by immunohistochemistry using an antiserum to EGR1 in the presence (Fig. 4 A, C, and E) or absence ( Fig. 4 B, D, and F) of an EGR1-blocking peptide. Although no clear signal was seen in the presence of the blocking peptide, staining of eyes from E13.5 mice demonstrated robust nuclear staining of a subpopulation of mesenchymal cells in the developing eyelids, orbit, and periocular tissues as well as in the epithelia of the developing lens and conjunctival sac (Fig. 4B ). Strong nuclear EGR1 staining was absent from the neuro-ectoderm-derived presumptive retinal pigment epithelium (RPE) and neural retina (Fig. 4B) . By E15.5, EGR1 staining was prominent in the surface epithelium covering the now-closed eyelids as well as at the base of the developing cilia (eyelashes) (Fig. 4D) . At day E17.5, staining was most prominent at the base of hair follicles and in scattered mesenchymal cells (Fig. 4F ). Similar results were observed when sections from E15.5 embryos from BALB/c WT mice were stained with an antiserum to EGR1 in the presence (Fig. 4G ) or absence ( Fig. 4H ) of an EGR1-blocking peptide. Prominent EGR1 staining was detected at the base of the developing cilia at the leading edge of the eyelid (Fig. 4H) . Thus, Egr1 is indeed expressed in the developing eye, including in the eyelid. Given the expression of EGR1 in the eyelid and the defective eyelid development in Egr1-deficient BALB/c background mice, it will be interesting in the future to perform microdissection and subsequent RNA-sequencing (RNA-seq) of eyelid regions in BALB/c WT and KO embryonic mice; this investigation might provide more information related to the genes that are important for eyelid development.
Mutations of EGR1 Were Not Found in Patients with Coloboma and
Multiple Congenital Anomaly Syndrome. Given the abnormalities that we observed in Egr1-deficient BALB/c mice, we wondered if EGR1 deficiency might be associated with congenital ocular abnormalities in humans as well. "Congenital ocular coloboma" refers to defects in which normal tissue in or around the eye is absent from birth and has been reported in 3-11% of blind children worldwide. Typical coloboma-a defect in the inferonasal quadrant of the iris, retina/RPE/choroid and/or optic nerve-is caused by failure of the ventral optic fissure to close during the fifth week of human gestation (18) . Rarely, coloboma and posterior staphyloma are reported in isolated cases (19, 20) . To evaluate whether EGR1 might be responsible for a subset of patients with coloboma, 67 unrelated patients with this disease were analyzed, but no mutations were identified in the EGR1 coding regions or adjacent intronic regions, indicating that mutations in EGR1 do not explain the occurrence of coloboma in these patients. We also screened 88 multiple congenital anomaly (MCA) patients available to us for EGR1 mutations and detected a heterozygous variant involving nt1600 (C to T), P443L, in one patient. Although this variant has not been recorded in the Ensembl database, heterozygosity suggests that this change is unlikely to be responsible for the defects in this patient.
Identification of Differentially Expressed Genes in
Mice. A common abnormality in the Egr1 −/− BALB/c mice was corneal neovascularization. Previously, it was reported that the proinflammatory cytokine IL-1β can induce neovascularization in both C57BL/6 and BALB/c mice (21) . We thus measured ocular Il1b mRNA levels and found the levels were increased in adult Egr1 −/− BALB/c mice but not in Egr1 +/+ BALB/c, Egr1 +/+ C57BL/6, or Egr1 −/− C57BL/6 mice (Fig. 5A) . Similarly, Il1b mRNA was increased in the eyes of newborn Egr1 −/− BALB/c mice but not in Egr1 +/+ BALB/c or Egr1 +/− BALB/c mice (Fig. 5B) , suggesting that IL-1β may be involved in the development of ocular anomalies in Egr1 −/− BALB/c mice. We therefore backcrossed C57BL/6 mice homozygous for the Il1r tm1Imx -targeted mutation, which prevents responsiveness to IL-1, to BALB/c for five generations and then crossed these mice to F5 Egr1 −/− BALB/c mice to generate double-KO mice. As expected, most (six of seven) Egr1 −/− BALB/c mutant mice had defects in one or both eyes, but all four Il1r tm1Imx Egr1 −/− BALB/c double-KO mice also had defects related to one or both eyes (Table S3 ), indicating that disease still progressed even when IL-1β could not function, as is consistent with contributions by other cytokines or growth factors.
To identify other genes that potentially contribute to the ocular phenotype, RNA-seq was performed with RNA from eyes from adult Egr1 −/− BALB/c mice (see Dataset S1A for the complete RNA-seq data). RNA-seq results confirmed higher Il1b expression in Egr1 −/− BALB/c mice than in WT mice. In addition, there was increased expression of cytoskeleton genes, including the Krt1, Krt16, Lor, Sprr family, and Lce family genes, which are involved in the process of cornification in which an epidermal barrier is formed in stratified squamous epithelial tissue. We also identified increased expression of several kallikrein genes that are involved in the regulation of blood pressure and activation of inflammation. Interestingly, the expression of γ-crystallin genes, Cryga and Cryge, was significantly lower in Egr1 −/− BALB/c mice. Crystallins are the main structural proteins of the vertebrate ocular lens, and their appropriate arrangement is critical for lens transparency, with mutations in the Cryg genes leading mainly to lens opacification and cataracts (22, 23) .
Because we found that internal ocular anomalies occurred after birth, we also performed RNA-seq analyses using eyes from newborn Egr1 −/− BALB/c mice, revealing increased expression of some of the genes identified in adult mice (see Dataset S1B for the complete RNA-seq data, comparing gene expression in "open" vs. "closed" eyes). In addition to cytoskeleton genes related to cornification, many more keratin genes are highly expressed in Egr1 −/− BALB/c mice, suggesting keratinization at an early age. In one Egr1 −/− BALB/c mouse, the expression of many crystallin and lens protein genes was strikingly decreased, possibly explaining why Egr1 −/− BALB/c mice often develop cataracts. Because in some Egr1 −/− BALB/c mice, one eye had normally formed eyelids and a relatively normal ocular structure, whereas the other eye had unmerged eyelids and malformed ocular structure, we performed RNA-seq using RNA from each eye of three 3-d-old Egr1 −/− mice with unmerged eyelids and from Egr1 +/− littermate controls. A multidimensional scaling (MDS) plot shows that geneexpression profiles in eyes from Egr1 −/− mice with unmerged eyelids (eyes that appeared open) were very different from those in eyes from either Egr1 +/− or Egr1 −/− mice in which the eyelids formed normally (see Fig. 5C and Dataset S2 for the complete RNA-seq data), suggesting that normally closed eyelids prevented ocular anomalies. To identify genomewide targets of EGR1-regulated genes that are important for eye development, differentiation, and function, we analyzed differential gene expression in eyes from mice without or with eyelid closure. We identified 854 and 37 genes that were significantly up-or down-regulated [fold change (FC) >2, P < 0.05], respectively, in eyes with defective eyelid closure (Fig.  5D) . We identified the top 50 most differentially expressed genes, displayed by heat map ( Fig. 5E ; sorted by P value) and volcano plot (Fig. 5F ). Very interestingly, Sprr1a (24), Krt16 (25), and Il1b, which previously had been shown to be involved in the development of ocular disease, were highly up-regulated in eyes without eyelids (Fig. 5G) . Our data overall suggest that the differences in gene expression are secondary to the failure of eyelid formation rather than directly caused by the absence of Egr1.
The Role of the Tyr Gene in the Ocular Abnormalities. A major difference between C57BL/6 (black) and BALB/c (albino) mice is eye and skin pigmentation. Interestingly, the enzyme tyrosinase, which catalyzes the first two steps of melanin biosynthesis, was previously identified as a modifier of the trabecular meshwork phenotype in a mouse model of human primary congenital glaucoma in which the presence of the homozygous Tyr c-2J allele conferred much more severe developmental defects to Cyp1b −/− mice (26) . Because homozygous Tyr c-2J mice are on a C57BL/6 background but are phenotypically indistinguishable from BALB/c mice, which harbor the mutant Tyr c allele, we investigated whether the Tyr gene might contribute to the eyelid abnormalities we observed by crossing Egr1 −/− C57BL/6 mice to Tyr c-2J homozygous mice. Strikingly, although all pigmented Egr1 −/− C57BL/6 mice had normal eyes (Fig. 6A) , 7 of 12 albino Tyr c-2J homozygous Egr1 −/− C57BL/6 mice developed ocular anomalies. These abnormalities tended to be milder than those in the BALB/c background, with keratitis, corneal neovascularization (Fig. 6B) , cataracts, anterior synechiae, retinal dysplasia, anterior segment angle defect, and persistent hyperplastic primary vitreous (PHPV) (Fig. 6 C and D and Table S4 ), and two albino Egr1 −/− C57BL/6 mice exhibited full-thickness corneal defects with invasion of epithelium (Fig. 6C) as well as staphyloma (Fig. 6D) . We did not observe staphyloma in any Egr1 −/− BALB/c mice. Thus, although the Tyr c-2J homozygous mutation increased ocular abnormalities in Egr1 −/− C57BL/6 mice, the phenotype was less severe than and was somewhat different from that observed in Egr1 −/− BALB/c mice, indicating that additional modifier gene(s) may contribute to the ocular phenotype of Egr1 −/− BALB/c mice.
Discussion
The vertebrate eye is a complex structure composed of three major unique tissues, the cornea, the lens, and the retina, the development of which involve highly organized and complex cascades of multiple transcription factors and signals. Mutations in key genes E17.5 E18.5 cause a number of congenital eye disorders (27) . Previous genetic studies in zebrafish, flies, chicken, mice, and humans have revealed many key steps in eye development (reviewed in refs, 27 and 28). We report here that Egr1 mutation in the BALB/c background mice leads to variable ocular anomalies associated with defective eyelid formation. Interestingly, in chicks exposed to positive or negative lenses to induce defocus, Egr1 expression was increased with positive lenses that suppress ocular elongation and decreased with negative lenses that enhance ocular elongation (29, 30) .
Consistent with this observation, Egr1
−/− mice have longer eyes with a relative myopic shift in refraction, with additional minor effects on anterior chamber depth and corneal radius of curvature (31) ; however, analysis of humans with myopia did not reveal EGR1 abnormalities (32) . Egr1 contributes to oculogenesis in zebrafish (33) , with arrested retinal and lenticular development and smaller lenses when morpholino oligonucleotides targeting Egr1 mRNA were microinjected into zebrafish embryos. Our current study identifies EGR1 defects associated with eyelid formation; the overall ocular anomalies caused by the absence of eyelid we have observed in this study are more severe, including cryptophthalmos, anophthalmia, microphthalmia, retinal dysplasia, keratitis, corneal neovascularization, and cataracts.
Strikingly, we found a fairly normal internal morphology of the eye in E14.5-E18.5 Egr1 −/− BALB/c embryos, but eyelid abnormalities were profound. Although both eyelids formed normally and merged in all Egr1 +/− BALB/c embryos at E17.5-E18.5, most eyelids were still underdeveloped in littermate Egr1 −/− BALB/c embryos. That the ocular structure was either normal or only mildly malformed when eyelids formed (Table   S1 ), compared with their being open in Egr1 −/− BALB/c neonatal mice, suggests that open eyelids allowed exposure of the cornea to drying, infection, or other damage, resulting in corneal neovascularization, keratitis, and even perforation, as well as other additional ocular anomalies. This interpretation is further supported by the observation that ocular anomalies were much severe at postnatal days 3 and 4 than at postnatal days 1 and 2 (Table S1) .
During ocular development, each layer of the eye is progressively induced by another; retina is formed first; retina formation induces lens development, which in turn induces cornea formation, which finally induces proper eyelid formation. Thus, eyelid defects can be secondary to ocular maldevelopment. However, when we compared the internal structure of eyes from E14.5 Egr1 +/− BALB/c and Egr1 −/− BALB/c embryos, no abnormality was found (Fig. S2) . This result suggests that the eyelid defect reported here is not secondary to ocular maldevelopment, although we cannot exclude the possibility that a separate, primarily ocular role of EGR1 contributes to the postnatal microphthalmia and is coincident with defective eyelid malformation. Interestingly, MEK kinase 1 (MEKK1), which is required for JNK activation by TGF-β, was previously shown to result in defective embryonic eyelid closure (34) . Moreover, TGF-β can stimulate the expression of EGR1, and this TGF-β-induced increase in EGR1 is blocked by a MEK1 inhibitor (35) . Our findings therefore may help clarify these prior observations further, although the genetic background-specific phenotype we observe is distinctive, given that the Mekk1-deficient mice had been crossed to C57BL/6 mice (34).
Patients with coloboma and with MCA have a different array of ocular problems. We performed sequence analysis of EGR1 in 67 patients with coloboma and 88 patients with MCA and found no mutations, indicating that EGR1 mutations in humans are not responsible for these diseases. Interestingly, no pathologic mutations have been reported in the EGR1 gene in humans, although Differences in dimension 1 (Dim1, x axis) indicates greater differences in samples than do differences in dimension 2 (Dim 2, y axis). (D) 2D scatter plot shows expressed genes. Genes highlighted in blue, green, and orange indicate differentially expressed genes with jlog2FCj>3, (jlog2FCj>2), and jlog2FCj>1, respectively. "log2FC" refers to the log (base 2) of the fold change of mRNA expression in eyes with unformed eyelids vs. eyes with formed eyelids. log2CPM, log base 2 of counts per million. EGR1 expression has been associated with tumorigenesis in various cancers (4) .
Previous reports suggested that the inflammatory cytokine IL-1β induces neovascularization in the mouse cornea (21) . When we measured the ocular Il1b mRNA levels, there was a large increase only in Egr1 −/− BALB/c adult and newborn mice, but not in Egr1
BALB/c and Egr1 −/− C57BL/6 mice ( Fig. 5 A and B) . This observation suggests that IL-1β may be involved in the keratitis and corneal neovascularization occurred in Egr1 −/− BALB/c mice and possibly in the further development of other ocular anomalies. However, when we generated Il1r tm1Imx
Egr1
−/− BALB/c double-KO mice, they also exhibited ocular malformation, suggesting that IL-1β is not a modifier in this case but rather that the increased level of IL-1β expression could be secondary to keratitis and ocular inflammation in Egr1 +/+ BALB/c mice. RNA-seq revealed differential expression of several cytoskeleton genes related to cornification, especially some of the keratin genes, which may lead to the increased keratinization we observed. In one mouse, we also observed the differential expression of many other genes, including crystallins, which are involved in cataract formation; the expression of Bfsp1 (filesin) and Bfsp2 (phakinin) mRNA also was decreased significantly in this mouse. These genes encode lens cell-specific intermediate filaments that are believed to promote the maintenance of lens transparency (36) . In addition, the expression of other lens proteins, including Mip, Lim2, Gja3, and Lenep, were significantly lower in this particular mouse. A mutation in the Mip gene causes the Fraser cataract phenotype in mice (37) . MIP is the most abundant (50-60%) intrinsic membrane protein of the lens fiber (38) . A mutation in the mouse Lim2 gene causes total opacity of the lens with a dense cataract combined with microphthalmia. In Lim2-mutant mice, the lens capsule ruptures posteriorly with lens material leaking into the vitreous chamber (39) . Gja3 genetargeted null mice developed lens nuclear cataracts shortly after birth (40) . Taken together, down-regulation of these genes may result in the formation of the cataracts frequently observed in Egr1 −/− BALB/c mice. It has been reported previously that kittens and puppies open their eyelids at about 10-14 d of age and that premature opening results in corneal desiccation, keratitis, corneal ulceration, and conjunctivitis, because several weeks are required for tear production to reach adequate levels. If these consequences are not treated (e.g., with a topical lubricating ophthalmic ointment), corneal perforation and endophthalmitis may occur (41) . Such observations support our model proposing that the ocular defects we observed are secondary to defective eyelid closure.
Remarkably, we observed ocular abnormalities in Egr1 −/− mice on the BALB/c but not C57BL/6 background, suggesting strainspecific modifier genes. One major difference between the two stains is pigmentation, which seemed potentially germane given that melanin pigment is produced in the uveal melanocytes and retinal pigment epithelium of the eye as well as by neural crestderived melanocytes found in skin (42) . The albino phenotype in BALB/c mice results from deficient activity of tyrosinase, which catalyzes the first two steps of melanin biosynthesis. A naturally arising G-to-C (Tyr c ) transversion, resulting in a Ser-to-Cys mutation at codon 103, results in a loss of tyrosinase activity (42) . Albino (homozygous for the Tyr c-2J allele) Cyp1b −/− mice have extensive developmental defects compared with pigmented Cyp1b −/− mice; these defects identify tyrosinase as a modifier in a model of developmental glaucoma (26) . The Tyr c-2J mutation, a G-to-T transversion resulting in an Arg-to-Leu substitution at codon 77, occurred spontaneously in C57BL/6 mice, and homozygous Tyr C57BL/6 mice, we found relatively mild defects (Table S4) , although one Tyr c-2J homozygous (albino) Egr1 −/− C57BL/6 mouse exhibited a full-thickness defect in the cornea (Fig. 6C) . Thus, although the Tyr c-2J mutation confers a susceptibility to ocular abnormalities in Egr1 −/− C57BL/6 mice, these abnormalities are much less severe than those observed in Egr1 −/− BALB/c mice, and there was no obvious defect in eyelid formation because the animals we examined were born with closed eyelids. In the future, it will be interesting to determine if the severity of the ocular defect is diminished if one analyzes Egr1 −/− BALB/c background mice that no longer carry an albino phenotype.
In summary, we here report striking defects in eyelid formation in Egr1 −/− mice on the BALB/c but not the C57BL/6 background, with profound ocular defects resulting from these eyelid defects. Our data implicate Tyr as one modifier gene but also suggest the existence of additional modifier gene(s) to explain the strain specific-defects, an area for future investigation.
Materials and Methods
Mice. All animal experiments used protocols approved by the National Heart, Lung, and Blood Institute (NHLBI) Animal Use and Care Committee and followed NIH guidelines for humane animal use. -targeted mutation (stock number 3245; Jackson Laboratory) were backcrossed to BALB/c mice for five generations and then were crossed with F5 Egr1 −/− BALB/c mice to generate double-KO mice. Adult mice were examined between 6 and 21 wk of age.
Ocular Examination. Eyelids, conjunctivae, corneas, anterior chambers, irises, lenses, and retinas of embryonic, neonatal, and adult mice were examined under a slit-lamp biomicroscope (Space Coast Laser, Inc.) and/or dissecting microscope.
Histology and Immunohistochemistry. Eyes including the eyelids from neonatal and adult mice were enucleated and fixed in 4% glutaraldehyde for 30 min, in 10% formalin for >24 h, embedded in methacrylate, and sectioned via a vertical pupillary-optic nerve plane. Mouse embryos were decapitated, and whole heads were fixed in 10% formalin for >24 h, embedded in methacrylate, and sectioned in the coronal plane through the pupillary-optic nerve axis. Specimens that contained bone (osseous tissue) were deparaffinized in xylenes and rehydrated through graded ethanols. Each eye was cut and stained with H&E. For EGR1 staining, C57BL/6 mouse embryos were fixed in 10% buffered formalin, embedded in paraffin, and serial sections (5 μm thick) were cut for histology and immunohistochemistry. Endogenous peroxidase was blocked with 3% H 2 O 2 . Sections then were subjected to antigen retrieval using a citrate buffer (BioGenex) for 10 min at 100°C. Following a 5% normal goat serum block, three sets of slides were incubated overnight at 4°C with (i) Egr1 Ab (rabbit mAb) (no. 4153; Cell Signaling Technology) at 1:100, (ii) Egr1 Ab/ blocking peptide (no. 1015; Cell Signaling Technology) mix (1:2 by volume), and (iii) rabbit monoclonal IgG isotype control reagent (no. 3900; Cell Signaling Technology). Slides were rinsed, and biotinylated goat anti-rabbit IgG (Vector Labs) that had been diluted 1:100 in TBS-Tween was applied for 30 min. After rinsing in TBS-Tween, Avidin Biotin Complex (Peroxidase ABC kit; Vector Labs) was applied to the slides for 30 min. Localization was visualized by incubation in diaminobenzidine (DAB) substrate for 5 min. Sections were counterstained with H&E, and then coverslips were added.
RNA Isolation and RT-PCR Analysis. Eyes were enucleated and placed into Eppendorf tubes filled with RNAlater (Thermo Fisher), and total RNA was extracted using the RNeasy Mini Kit (Qiagen). The first strand was reversetranscribed using the Omniscript Reverse Transcription Kit (Qiagen) and random primers. Real-time quantitative PCR was performed on a 7900HT Real-time PCR system (Applied Biosystems) using real-time primers and TaqMan probes for Il1b from Applied Biosystems. Expression was normalized to that of Rpl7.
RNA-Seq Analysis. Poly(A) + RNA was selected twice from total RNA using Dynal oligo magnetic beads (Invitrogen). Double-stranded cDNA was synthesized using SuperScript (Invitrogen) and fragmented using Bioruptor (Diagenode). Adaptors (Illumina) were ligated to the dsDNA using T4 DNA ligase (New England Biolabs) after end repair using the End-It Kit (Epicentre) and dA addition. Libraries were size-selected for 250-to 400-bp fragments, purified using 2% E-Gel (Invitrogen), and amplified for 18 cycles by PCR with PE 1.0 and PE 2.0 primers (Illumina) and Phusion High Fidelity PCR Master
